Bausch + Lomb stock surged amid reports of a potential sale, with private equity seen as the likely buyer due to antitrust challenges for other companies. The parent company, Bausch Health, faces patent litigation.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing